नया
FebriDx® Rapid Respiratory Test
0 समीक्षा
प्रकाशित द्वारा RCS Healthcare
$637.50 (USD)
- स्थान: United States
- दर्जा: स्टॉक में
विवरण
FebriDx® Rapid Respiratory Test is a rapid point-of-care **** that differentiates bacterial infections from non-bacterial pathogens. In 10 minutes, this portable **** allows medical providers to initiate the correct treatment and a**** the overuse of antibiotics.
Features and Benefits:
Allows medical providers to identify or rule out bacterial infections
Delivers results within 10 minutes
No equipment necessary
Reduces the need to write antibiotic prescriptions
99% Negative predictive value
CLIA Moderate Waived Test
संबंधित उत्पाद
